ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma-Reference-Cited by-同舟云学术

ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma

Author:

Yu Q. N.¹,Guo Y. B.²,Li X.³,Li C. L.¹,Tan W. P.²,Fan X. L.¹,Qin Z. L.¹,Chen D.¹,Wen W. P.¹,Zheng S. G.⁴⁵,Fu Q. L.¹

Affiliation:

1. Otorhinolaryngology Hospital; The First Affiliated Hospital; Sun Yat-sen University; Guangzhou China

2. Department of Respiratory; The First Affiliated Hospital; Sun Yat-sen University; Guangzhou China

3. Department of Emergency; Guangdong General Hospital; Guangdong Academy of Medical Science; Guangzhou China

4. Department of Clinical Immunology; The Third Affiliated Hospital; Sun Yat-sen University; Guangzhou China

5. Milton S. Hershey Medical Centre; Penn State University; Hershey PA USA

Funder

National Natural Science Foundation of China

Science and Technology Foundation of Guangdong Province of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

Reference39 articles.

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献